Skip to main content

Table 3 Comparison of prospective study patients with historical control group

From: A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients

 

Prospective study patients

Historical control group n = 27

P value

Age (mean ±SD)

44 ±14 years

49 ±13 years

P=0.14

Male

62%

85%

P=0.03

Race/ethnicity:

Caucasian

69%

41%

P=0.21

Indian subcontinent

11%

4%

 

Other

20%

22%

 

Missing

0%

33%

 

Cause of ESRD:

Glomerular

25%

33%

 

Polycystic disease

18%

11%

 

Other known cause

51%

41%

 

Unknown

6%

15%

P=0.41

BMI:

Mean ±SD

28 ±5

29 ±6

P=0.57

≤30

70%

56%

P=0.23

>30

30%

33%

 

Missing

0%

11%

 

Preemptive transplantation

27%

37%

P=0.34

Living donor

96%

22%

P<0.0001

Diabetes at 6 months:

Euglycemic

88%

67%

P=0.07

Impaired

8%

15%

 

NODAT

4%

18%

 

AR at 6 months

2%

15%

P=0.033

  1. AR, acute rejection; BMI, body mass index; ESRD, end stage renal disease; NODAT, new onset diabetes after transplantation; SD, standard deviation.